Corcept Therapeutics, Inc. (CORT)
72.96
-0.75
(-1.02%)
USD |
NASDAQ |
Nov 13, 16:00
72.96
0.00 (0.00%)
After-Hours: 16:53
Corcept Therapeutics EPS Diluted (Quarterly) : 1.010 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.010 |
| June 30, 2026 | 0.356 |
| March 31, 2026 | -0.2988 |
| December 31, 2025 | 0.1994 |
| September 30, 2025 | 0.1621 |
| June 30, 2025 | 0.2873 |
| March 31, 2025 | 0.1693 |
| December 31, 2024 | 0.2565 |
| September 30, 2024 | 0.4106 |
| June 30, 2024 | 0.3157 |
| March 31, 2024 | 0.2503 |
| December 31, 2023 | 0.2808 |
| September 30, 2023 | 0.2806 |
| June 30, 2023 | 0.2496 |
| March 31, 2023 | 0.1369 |
| December 31, 2022 | 0.1423 |
| September 30, 2022 | 0.2963 |
| June 30, 2022 | 0.2375 |
| March 31, 2022 | 0.1982 |
| December 31, 2021 | 0.2618 |
| September 30, 2021 | 0.2435 |
| June 30, 2021 | 0.2094 |
| March 31, 2021 | 0.181 |
| December 31, 2020 | 0.204 |
| September 30, 2020 | 0.1737 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.2299 |
| March 31, 2020 | 0.246 |
| December 31, 2019 | 0.2395 |
| September 30, 2019 | 0.2163 |
| June 30, 2019 | 0.1658 |
| March 31, 2019 | 0.1475 |
| December 31, 2018 | 0.1758 |
| September 30, 2018 | 0.1407 |
| June 30, 2018 | 0.1427 |
| March 31, 2018 | 0.1367 |
| December 31, 2017 | 0.7721 |
| September 30, 2017 | 0.1095 |
| June 30, 2017 | 0.1028 |
| March 31, 2017 | 0.0362 |
| December 31, 2016 | 0.04 |
| September 30, 2016 | 0.02 |
| June 30, 2016 | 0.01 |
| March 31, 2016 | -0.0002 |
| December 31, 2015 | 0.01 |
| September 30, 2015 | -0.01 |
| June 30, 2015 | -0.02 |
| March 31, 2015 | -0.05 |
| December 31, 2014 | -0.04 |
| September 30, 2014 | -0.06 |
| June 30, 2014 | -0.07 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.5637 |
| Phibro Animal Health Corp. | 0.7208 |
| Illumina, Inc. | 1.429 |
| Eli Lilly & Co. | 7.221 |
| Merck & Co., Inc. | 2.044 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 124.49M |
| Revenue (Quarterly) | 340.47M |
| Total Expenses (Quarterly) | 215.98M |
| Enterprise Value | 7.700B |
| Gross Profit Margin (Quarterly) | 98.65% |
| Profit Margin (Quarterly) | 36.56% |
| Earnings Yield | 1.74% |
| Operating Earnings Yield | 1.31% |
| Normalized Earnings Yield | 1.737 |